BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8181520)

  • 1. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen.
    Schirmbeck R; Melber K; Mertens T; Reimann J
    Eur J Immunol; 1994 May; 24(5):1088-96. PubMed ID: 8181520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
    Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
    J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
    Kuhöber A; Pudollek HP; Reifenberg K; Chisari FV; Schlicht HJ; Reimann J; Schirmbeck R
    J Immunol; 1996 May; 156(10):3687-95. PubMed ID: 8621903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo.
    Schirmbeck R; Böhm W; Reimann J
    Eur J Immunol; 1994 Sep; 24(9):2068-72. PubMed ID: 8088327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
    Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
    J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.
    Schirmbeck R; Deml L; Melber K; Wolf H; Wagner R; Reimann J
    Vaccine; 1995 Jun; 13(9):857-65. PubMed ID: 7483809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
    Kuhröber A; Schirmbeck R; Reimann J
    Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
    Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
    Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
    Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C
    Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.
    Schirmbeck R; Melber K; Mertens T; Reimann J
    J Virol; 1994 Mar; 68(3):1418-25. PubMed ID: 8107205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation.
    Schirmbeck R; Böhm W; Melber K; Reimann J
    J Immunol; 1995 Nov; 155(10):4676-84. PubMed ID: 7594467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes.
    Schirmbeck R; Zerrahn J; Kuhröber A; Deppert W; Reimann J
    Eur J Immunol; 1993 Jul; 23(7):1528-34. PubMed ID: 8325328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.
    Schirmbeck R; Böhm W; Ando K; Chisari FV; Reimann J
    J Virol; 1995 Oct; 69(10):5929-34. PubMed ID: 7666497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytoxic T lymphocyte responses to hepatitis B virus small surface antigen in BALB/c mice].
    Shi L; Liu SR; Yi XR; Kong QQ; Zhang YJ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1242-4. PubMed ID: 14678879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses.
    Speidel K; Osen W; Faath S; Hilgert I; Obst R; Braspenning J; Momburg F; Hämmerling GJ; Rammensee HG
    Eur J Immunol; 1997 Sep; 27(9):2391-9. PubMed ID: 9341785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.